| LSSIX | VISGX | LSSIX / VISGX | |
| Total Expense Ratio | 0.93 | 0.19 | 489% |
| Annual Report Gross Expense Ratio | 0.93 | 0.19 | 489% |
| Fund Existence | 30 years | 28 years | - |
| Gain YTD | 23.019 | 17.346 | 133% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 100000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.19B | 47B | 5% |
| Annual Yield % from dividends | 0.00 | 0.31 | - |
| Returns for 1 year | 20.10 | 26.83 | 75% |
| Returns for 3 years | 30.77 | 51.09 | 60% |
| Returns for 5 years | -6.10 | 27.48 | -22% |
| Returns for 10 years | 59.95 | 180.44 | 33% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PABD | 68.51 | N/A | N/A |
| iSharesParis-AlgndClmOptdMSCIWldexUSAETF | |||
| ILOW | 45.37 | -0.35 | -0.77% |
| AB Active ETFs Inc. | |||
| SCDV | 27.27 | -0.23 | -0.84% |
| Bahl & Gaynor Small Cap Dividend ETF | |||
| XNTK | 357.98 | -10.88 | -2.95% |
| State Street® SPDR® NYSE Technology ETF | |||
| BBC | 51.34 | -1.82 | -3.43% |
| Virtus LifeSci Biotech Clinical Trls ETF | |||